Upadacitinib: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "* JAK inhibitor that targets JAK1 * Indications include rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ankylosing spondylitis, Crohn disease, and ulcerative colitis * Adverse effects include: upper respiratory tract infection, nausea, hepatotoxicity * Reports of lymphopenia, neutropenia, and anemia Category:Medications Category:Rheumatology" |
(No difference)
|
Latest revision as of 14:44, 23 September 2024
- JAK inhibitor that targets JAK1
- Indications include rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ankylosing spondylitis, Crohn disease, and ulcerative colitis
- Adverse effects include: upper respiratory tract infection, nausea, hepatotoxicity
- Reports of lymphopenia, neutropenia, and anemia
